Eye-minders

Eye-Minders is a deep-tech company developing patented AI algorithms that analyze eye movements and pupil dynamics to extract biomarkers of cognitive and emotional load.

Health Tech & Life Sciences
Active
Series A Haifa, Israel Founded 2018
Last updated 2026-07-20
Total raised
$5.8M
Last: Undisclosed Round 2024-03
Stage
Series A
Founded
2018
Headcount
6
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

Eye-Minders is a deep-tech company that develops patented AI algorithms to analyze eye movements and pupil dynamics, extracting biomarkers of cognitive and emotional load. Their technology is based on 15 years of R&D in eye-based technologies and is protected by patents and trade secrets. The company's first commercial product is for credibility assessment and is used by private companies and government agencies. Eye-Minders is expanding into clinical mental health, including a PTSD diagnostics pilot with MAFAAT (Israel's Directorate of Defense R&D) and leading hospitals like Sheba Medical Center. They also offer solutions for AR/VR/XR headsets to decipher user's inner world, aiming to improve user wellness, enhance gaming experiences, and improve monetization by detecting and minimizing cybersickness and stress.

Funding history · 1 round · $5.8M total

2024-03
Undisclosed Round $5.8M

Headcount over time

From 7 (2024-03) to 6 (2025-10) · -1 (-14%) · 5 points · source: Finder history + radar grounding
90 2024-03 2025-10

Q&A

What is Eye-minders' primary focus?
Eye-minders is a deep-tech company that develops patented AI algorithms to analyze eye movements and pupil dynamics, extracting biomarkers for cognitive and emotional load. They are expanding into clinical mental health.
When was Eye-minders founded?
Eye-minders was founded in October 2017.
What is Eye-minders' current employee count?
Eye-minders has 6 employees, falling within the 1-10 employee bucket.
What is the total amount of funding Eye-minders has raised to date?
Eye-minders has raised a total of $5,800,000 USD.
When was Eye-minders' last funding round and who participated?
Eye-minders' last funding round was in March 2024, with participation from Israel Innovation Authority.
What is Eye-minders' current funding stage?
Eye-minders is currently in the Series A funding stage.
What is Eye-minders' first commercial product used for?
Eye-minders' first commercial product is for credibility assessment and is currently utilized by private companies and government agencies.
Which organization selected Eye-minders to lead a PTSD diagnostics pilot?
MAFAAT (Israel’s Directorate of Defense R&D) selected Eye-minders to lead a PTSD diagnostics pilot, in collaboration with hospitals including Sheba Medical Center.

Team · 1

Dr. Daphna Palti-Wasserman
Founder · Founder & CEO/CTO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient EngagementDigital TherapeuticsDigital Medical Diagnostics
Technologies
SensingOpticSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & Family
Business model
B2C

Tags

eye-trackingmental-health
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteeye-minders.com/
LinkedInlinkedin.com/company/33299390
Facebookfacebook.com/eyeminders/

Identifiers & details

Legal nameEYE-MINDERS LTD
Founded2018
Employees (exact)6

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domaineye-minders.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515731354
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2017-10-16
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events5 — annual_report (4), violation (1)
Registered addressשבדיה 11 חיפה

Recent registry events

DateEvent
2026-06-17דו~ח שנתי-הסרת בעל תפקיד
2026-06-17דו~ח שנתי-הוספת בעל תפקיד
2026-06-17דו~ח שנתי-עדכון כתובת
2026-06-17דו~ח שנתי-שינוי בהוראות בתקנון
2026-06-17עדכון הפרה